Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: Nucl Med Biol. 2010 May;37(4):479–486. doi: 10.1016/j.nucmedbio.2010.01.006

Table 1.

Regional Brain Distribution of [18F]FPBM after iv injection of (% dose/gram ± SD)

PCA Inhibition
60 min (n = 6)
Control
60 min (n = 6)

Cerebellum 0.08 ± 0.01 0.14 ± 0.04
Striatum 0.24 ± 0.07 0.53 ± 0.09
Hippocampus 0.19 ± 0.03 0.45 ± 0.10
Cortex 0.16 ± 0.04+ 0.49 ± 0.12+
Remainder 0.19 ± 0.03 0.45 ± 0.10
Hypothalamus 0.32 ± 0.05* 0.66 ± 0.09*
Ratio vs. CB ± SD
PCA Inhibition
60 min (n = 6)
Control
60 min (n = 6)

Cerebellum 1.00 ± 0.34 1.00 ± 0.33
Striatum 2.90 ± 1.00 3.70 ± 1.21
Hippocampus 2.29 ± 0.56 3.09 ± 1.10
Cortex 1.93 ± 0.58 3.39 ± 1.28
Remainder 2.27 ± 0.53 3.12 ± 1.12
Hypothalamus 3.87 ± 0.88 4.61 ± 1.44
+

Cortex Inhibition: 68% reduction

*

Hypothalamus Inhibition: 52% reduction